People · Operator
Named in public records as an officer, director or promoter · active 2010–2022 · Pharmaceuticals, Agriculture, Other Health Care, Biotechnology, Agtech / Foodtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vasculox, Inc. | — | Pharmaceuticals | Series B | $42.6M | $1.1B | 2014 |
| CoverCress Inc. | — | Agriculture | Series B | $36.7M | $184.9M | 2018 |
| Plastomics Inc. | — | Agriculture | Series A | $12.7M | $47.8M | 2017 |
| Indalo Therapeutics, Inc. | — | Pharmaceuticals | Series A | $9.7M | $278.7M | 2014 |
| Confluence Life Sciences, Inc. | — | Other Health Care | Series A | $5.7M | $97.5M | 2010 |
| Canopy Biosciences, LLC | — | Biotechnology | Seed | $3.2M | $92.1M | 2016 |
| Solis Agrosciences Inc. | — | Agriculture | Seed | $3.1M | $16.8M | 2022 |
| Impetus Agriculture, Inc. | — | Agtech / Foodtech | Pre-Seed | $915K | $11.4M | 2020 |
| Tansna Therapeutics, Inc. | — | Biotechnology | Pre-Seed | $850K | $1.1M | — |
| Nanopore Diagnostics, LLC | — | Biotechnology | Pre-Seed | $585K | $32.3M | 2015 |
Charles Bolten at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Charles Bolten on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.